Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: Hong Kong Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20092
20141
20161
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
The University of Hong Kong2
Clovis Oncology, Inc.1
Genentech, Inc.1
Gilead Sciences1
Merck KGaA, Darmstadt, Germany1
NantCell, Inc.1
Puma Biotechnology, Inc.1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis11
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Neoplasms2
Recurrence2
Adenocarcinoma1
Carcinoma, Hepatocellular1
Colonic Neoplasms1
Colorectal Neoplasms1
Lung Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.